PYC — Physiomics Share Price
Last trade - 00:00- £1.18m
- £0.91m
- £0.54m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.83 | ||
| Price to Tang. Book | 2.86 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.37 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -163.59% | ||
| Return on Equity | -116.39% | ||
| Operating Margin | -137.24% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 0.8 | 0.7 | 0.83 | 0.6 | 0.54 | 0.72 | n/a | -5.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Physiomics PLC is a United Kingdom-based company, which provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology. The Company offer its services by utilizing its proprietary Virtual Tumour predictive software, industry standard tools (such as NONMEM and MATLAB), as well as developing bespoke models using the R programming language. Virtual Tumour is a predictive quantitative systems' pharmacology (QSP) model used worldwide by global pharmaceuticals to small biotech companies to support oncology Research and development (R&D). It is a semi-mechanistic model that incorporates an abstracted representation of the cell cycle, Deoxyribonucleic acid (DNA) damage/ repair and elements of the immune response. The Company is also developing its technology for use in the field of personalized medicine. The Company is focused on helping pharma and biotech clients.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 30th, 2001
- Public Since
- December 20th, 2004
- No. of Employees
- 11
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- London Stock Exchange
- Shares in Issue
- 303,208,718
- Address
- Bee House, OXFORD, OX14 4SB
- Web
- https://www.physiomics.co.uk/
- Phone
- +44 1235841575
- Auditors
- Shipleys LLP
Latest News for PYC
Upcoming Events for PYC
Full Year 2025 Physiomics PLC Earnings Release
Similar to PYC
ADVFN
London Stock Exchange
Amcomri
London Stock Exchange
Andrews Sykes
London Stock Exchange
Anexo
London Stock Exchange
Ashtead
London Stock Exchange
FAQ
As of Today at 22:39 UTC, shares in Physiomics are trading at 0.39p. This share price information is delayed by 15 minutes.
Shares in Physiomics last closed at 0.39p and the price had moved by -66.09% over the past 365 days. In terms of relative price strength the Physiomics share price has underperformed the FTSE All Share Index by -67.42% over the past year.
There is no consensus recommendation for this security.
Find out morePhysiomics does not currently pay a dividend.
Physiomics does not currently pay a dividend.
Physiomics does not currently pay a dividend.
To buy shares in Physiomics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 0.39p, shares in Physiomics had a market capitalisation of £1.18m.
Here are the trading details for Physiomics:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: PYC
Based on an overall assessment of its quality, value and momentum Physiomics is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Physiomics. Over the past six months, its share price has underperformed the FTSE All Share Index by -41.29%.
As of the last closing price of 0.39p, shares in Physiomics were trading -41.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Physiomics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 0.39p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Physiomics' management team is headed by:
- Paul Harper - NEC
- Jim Millen - CEO
- Christophe David Chassagnole - COO